Mr Daniel Harris

Swansea University, Swansea (United Kingdom of Great Britain & Northern Ireland)

Follow

Contributor content

Early discontinuation of P2Y12 antagonist and adverse clinical outcomes post percutaneous coronary intervention

Presentation

Early discontinuation of P2Y12 antagonist and adverse clinical outcomes post percutaneous coronary intervention

ESC 365 is supported by

novartis

Explore sponsored resources